| Entry |
|
|---|
| Name |
Camidanlumab tesirine (USAN) |
|---|
| Formula |
C6548H10150N1732O2038S42
|
|---|
| Exact mass |
146999.2112
|
|---|
| Mol weight |
147089.84
|
|---|
| Efficacy |
Antineoplastic, Anti-IL-2 receptor alpha antibody |
|---|
| Type |
Antibody-drug conjugate |
|---|
| Comment |
Treatment of hematologic cancers
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04060 | Cytokine-cytokine receptor interaction |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
Cytokines and receptors
Cytokine receptors
Interleukin receptors
IL2RA (CD25)
D11325 Camidanlumab tesirine (USAN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
